First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

<p>Abstract</p> <p>Background</p> <p>This phase II study evaluated the efficacy and safety of gemcitabine (G) plus paclitaxel (T) as first-line therapy in recurrent or metastatic breast cancer.</p> <p>Methods</p> <p>Patients with locally, recurre...

Full description

Bibliographic Details
Main Authors: Piperno-Neumann Sophie, Tubiana-Mathieu Nicole, Tubiana-Hulin Michele, Gawande Sulochana R, Allouache Djelila, Mefti Fawzia, Bozec Laurence, Genot Jean-Yves
Format: Article
Language:English
Published: BMC 2005-11-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/5/151

Internet

http://www.biomedcentral.com/1471-2407/5/151

Similar Items